收藏切换
Progress on research and development of drug for chronic kidney disease and related comorbidities
收藏切换
PDF
Yi-ge YANG1, 2, He LI1, Xiu-li ZHANG1, Xiao-chuan TAN1, Yu-jia ZHANG1, Wen-sheng ZHENG1, *
Acta Pharmaceutica Sinica | 2022, 57(9) : 2682 - 2695
Less
收藏切换
Acta Pharmaceutica Sinica | 2022, 57(9): 2682-2695
Reviews
Progress on research and development of drug for chronic kidney disease and related comorbidities
Full
Yi-ge YANG1, 2, He LI1, Xiu-li ZHANG1, Xiao-chuan TAN1, Yu-jia ZHANG1, Wen-sheng ZHENG1, *
Affiliations
  • 1. Beijing City Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
  • 2. Tianjin University, Tianjin 100072, China
Published: 2022-09-12 doi: 10.16438/j.0513-4870.2022-0134
Outline
收藏切换

Chronic kidney disease (CKD) is a progressive disease with many complications (eg, cardiovascular disease and acidosis and anemia) and high morbidity and mortality occurs in the population. There is no cure for this disease, current treatments including renin-angiotensin-aldosterone pathway inhibitors and sodium-glucose co-transporter 2 inhibitors can only delay the progression to end-stage renal disease. With the identification of more key factors and mechanisms in CKD development, new potential therapeutic approaches for CKD can be developed. This review summarizes the mainstays of therapy and strategies for CKD and related comorbidities to support the development of novel treatments.

chronic kidney disease  /  comorbidity  /  drug development  /  end-stage renal disease  /  clinical trial drug
Yi-ge YANG, He LI, Xiu-li ZHANG, Xiao-chuan TAN, Yu-jia ZHANG, Wen-sheng ZHENG. Progress on research and development of drug for chronic kidney disease and related comorbidities[J]. Acta Pharmaceutica Sinica, 2022 , 57 (9) : 2682 -2695 . DOI: 10.16438/j.0513-4870.2022-0134
Year 2022 volume 57 Issue 9
PDF
162
73
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2022-0134
  • Receive Date:2022-01-27
  • Online Date:2025-12-24
  • Published:2022-09-12
Article Data
Affiliations
History
  • Received:2022-01-27
  • Revised:2022-03-26
Funding
Affiliations
    1. Beijing City Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
    2. Tianjin University, Tianjin 100072, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2022-0134
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT